1-6 of 6
Enric Carcereny
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ctDNA dynamics and mechanisms of acquired resistance in patients treated with osimertinib with or without bevacizumab from the randomised phase II ETOP-BOOSTER trial

Ross A. Soo, Urania Dafni, Ji-Youn Han, Byoung Chul Cho, Ernest Nadal, Chong Ming Yeo, Enric Carcereny, Javier de Castro, Maria Angeles Sala, Linda Coate, Mariano Provencio, Christian Britschgi, Patrick Vagenknecht, Georgia Dimopoulou, Roswitha Kammler, Stephen P. Finn, Solange Peters, Rolf A. Stahel
Journal: Clinical Cancer Research
Clin Cancer Res (2024)
https://doi.org/10.1158/1078-0432.CCR-24-0932
Published: 09 September 2024
View article titled, ctDNA dynamics and mechanisms of acquired resistance in patients treated with osimertinib with or without bevacizumab from the randomised phase II ETOP-BOOSTER trial
Open the PDF for ctDNA dynamics and mechanisms of acquired resistance in patients treated with osimertinib with or without bevacizumab from the randomised phase II ETOP-BOOSTER trial in another window
Includes: Supplementary data
Journal Articles

Eftilagimod Alpha (Soluble LAG3 Protein) Combined with Pembrolizumab as Second-Line Therapy for Patients with Metastatic Head and Neck Squamous Cell Carcinoma

Martin Forster, Irene Brana, Antonio L. Pousa, Bernard Doger, Patricia Roxburgh, Pawan Bajaj, Julio Peguero, Matthew Krebs, Enric Carcereny, Grisma Patel, Christian Mueller, Chrystelle Brignone, Frederic Triebel
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (17): 3726–3734.
https://doi.org/10.1158/1078-0432.CCR-24-0473
Published: 03 September 2024
View article titled, Eftilagimod Alpha (Soluble LAG3 Protein) Combined with Pembrolizumab as Second-Line Therapy for Patients with Metastatic Head and Neck Squamous Cell Carcinoma
Open the PDF for Eftilagimod Alpha (Soluble LAG3 Protein) Combined with Pembrolizumab as Second-Line Therapy for Patients with Metastatic Head and Neck Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung Cancer

Melina Peressini, Rosario Garcia-Campelo, Bartomeu Massuti, Cristina Martí, Manuel Cobo, Vanesa Gutiérrez, Manuel Dómine, José Fuentes, Margarita Majem, Javier de Castro, Juan F. Córdoba, María P. Diz, Dolores Isla, Emilio Esteban, Enric Carcereny, Laia Vila, Alberto Moreno-Vega, Silverio Ros, Amaia Moreno, Francisco J. García, Gerardo Huidobro, Carlos Aguado, Victor Cebey-López, Javier Valdivia, Ramón Palmero, Pilar Lianes, Marta López-Brea, Oscar J. Vidal, Mariano Provencio, Edurne Arriola, Javier Baena, Mercedes Herrera, Helena Bote, Magdalena Molero, Vera Adradas, Santiago Ponce-Aix, Angel Nuñez-Buiza, Álvaro Ucero, Susana Hernandez, Fernando Lopez-Rios, Esther Conde, Luis Paz-Ares, Jon Zugazagoitia
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (14): 3036–3049.
https://doi.org/10.1158/1078-0432.CCR-24-0104
Published: 15 July 2024
View article titled, Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung Cancer
Open the PDF for Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Nondisruptive p53 Mutations Are Associated with Shorter Survival in Patients with Advanced Non–Small Cell Lung Cancer

Miguel A. Molina-Vila, Jordi Bertran-Alamillo, Amaya Gascó, Clara Mayo-de-las-Casas, María Sánchez-Ronco, Laia Pujantell-Pastor, Laura Bonanno, Adolfo G. Favaretto, Andrés F. Cardona, Alain Vergnenègre, Margarita Majem, Bartomeu Massuti, Teresa Morán, Enric Carcereny, Santiago Viteri, Rafael Rosell
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (17): 4647–4659.
https://doi.org/10.1158/1078-0432.CCR-13-2391
Published: 01 September 2014
View article titled, Nondisruptive p53 Mutations Are Associated with Shorter Survival in Patients with Advanced Non–Small Cell Lung Cancer
Open the PDF for Nondisruptive p53 Mutations Are Associated with Shorter Survival in Patients with Advanced Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

The Impact of EGFR T790M Mutations and BIM mRNA Expression on Outcome in Patients with EGFR-Mutant NSCLC Treated with Erlotinib or Chemotherapy in the Randomized Phase III EURTAC Trial

Carlota Costa, Miguel Angel Molina, Ana Drozdowskyj, Ana Giménez-Capitán, Jordi Bertran-Alamillo, Niki Karachaliou, Radj Gervais, Bartomeu Massuti, Jia Wei, Teresa Moran, Margarita Majem, Enriqueta Felip, Enric Carcereny, Rosario Garcia-Campelo, Santiago Viteri, Miquel Taron, Mayumi Ono, Petros Giannikopoulos, Trever Bivona, Rafael Rosell
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (7): 2001–2010.
https://doi.org/10.1158/1078-0432.CCR-13-2233
Published: 31 March 2014
View article titled, The Impact of <em>EGFR</em> T790M Mutations and <em>BIM</em> mRNA Expression on Outcome in Patients with <em>EGFR</em>-Mutant NSCLC Treated with Erlotinib or Chemotherapy in the Randomized Phase III EURTAC Trial
Open the PDF for The Impact of <em>EGFR</em> T790M Mutations and <em>BIM</em> mRNA Expression on Outcome in Patients with <em>EGFR</em>-Mutant NSCLC Treated with Erlotinib or Chemotherapy in the Randomized Phase III EURTAC Trial in another window
Includes: Supplementary data
Journal Articles

Pretreatment EGFR T790M Mutation and BRCA1 mRNA Expression in Erlotinib-Treated Advanced Non–Small-Cell Lung Cancer Patients with EGFR Mutations

Rafael Rosell, Miguel Angel Molina, Carlota Costa, Sara Simonetti, Ana Gimenez-Capitan, Jordi Bertran-Alamillo, Clara Mayo, Teresa Moran, Pedro Mendez, Felipe Cardenal, Dolores Isla, Mariano Provencio, Manuel Cobo, Amelia Insa, Rosario Garcia-Campelo, Noemi Reguart, Margarita Majem, Santiago Viteri, Enric Carcereny, Ruth Porta, Bartomeu Massuti, Cristina Queralt, Itziar de Aguirre, Jose Miguel Sanchez, Maria Sanchez-Ronco, Jose Luis Mate, Aurelio Ariza, Susana Benlloch, Jose Javier Sanchez, Trever G Bivona, Charles L Sawyers, Miquel Taron
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (5): 1160–1168.
https://doi.org/10.1158/1078-0432.CCR-10-2158
Published: 01 March 2011
View article titled, Pretreatment EGFR T790M Mutation and BRCA1 mRNA Expression in Erlotinib-Treated Advanced Non–Small-Cell Lung Cancer Patients with EGFR Mutations
Open the PDF for Pretreatment EGFR T790M Mutation and BRCA1 mRNA Expression in Erlotinib-Treated Advanced Non–Small-Cell Lung Cancer Patients with EGFR Mutations in another window
Includes: Supplementary data